A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia

Treatment-resistant schizophrenia (TRS) will affect about one in three patients with schizophrenia. Clozapine is the only treatment approved for TRS, and patients should be treated as soon as possible to improve their chances of achieving remission. Despite its effectiveness, concern over side effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Correll, C. U., Agid, Ofer, Crespo-Facorro, Benedicto, de Bartolomeis, Andrea, Fagiolini, Andrea, Seppälä, Niko, Howes, Oliver D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Therapy in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243911/
https://www.ncbi.nlm.nih.gov/pubmed/35759211
http://dx.doi.org/10.1007/s40263-022-00932-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243911/
https://www.ncbi.nlm.nih.gov/pubmed/35759211
http://dx.doi.org/10.1007/s40263-022-00932-2

Ejemplares similares